Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma
Authors:
- 1 July 2017
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 67 (1) , 32-39
Abstract
No abstract availableKeywords
Funding Information
- Merit Review (I01CX000320, I01CX001156)
This publication has 36 references indexed in Scilit:
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular CarcinomaAnnals of Internal Medicine, 2013
- The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infectionHepatology, 2012
- Utilization of Surveillance for Hepatocellular Carcinoma Among Hepatitis C Virus–Infected Veterans in the United StatesAnnals of Internal Medicine, 2011
- Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral EradicationClinical Gastroenterology and Hepatology, 2010
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease ProgressionGastroenterology, 2010
- The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databasesAlimentary Pharmacology & Therapeutics, 2007
- Incidence and Predictors of Hepatocellular Carcinoma in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2007
- Predictors of response of U.S. veterans to treatment for the hepatitis C virusHepatology, 2007
- FIB-4Hepatology, 2007
- Who Has Diabetes? Best Estimates of Diabetes Prevalence in the Department of Veterans Affairs Based on Computerized Patient DataDiabetes Care, 2004